Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
08:30:42 EDT Tue 25 Aug 2026
Enter Symbol
or Name
USA
CA



Q:CPRX - CATALYST PHARMACEUTICALS INC - https://www.copper-ridge.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
CPRX - QHALTED31.49    32.56  19.05Jul 14Jul 1615 min RT 2¢

Recent Trades - All 0 today
Time ETExPriceChangeVolume
     
     
     
     
     
     
     
     
     
     

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-07-16 03:36U:CPRXNews ReleaseAngelini Pharma Completes Acquisition of Catalyst Pharmaceuticals
2026-07-09 17:47U:CPRXNews ReleaseSolaris Energy Infrastructure Set to Join S&P SmallCap 600
2026-06-30 08:03U:CPRXNews ReleaseVamorolone Demonstrates On-Target Glucocorticoid Activity Without the Immunosuppression Characteristic of Traditional Corticosteroids at Clinical Doses
2026-05-11 16:13U:CPRXNews ReleaseCatalyst Pharmaceuticals Reports First Quarter 2026 Financial Results
2026-05-07 16:02U:CPRXNews ReleaseCatalyst Pharmaceuticals Cancels First Quarter 2026 Conference Call and Webcast
2026-05-07 03:26U:CPRXNews ReleaseAngelini Pharma to Acquire Catalyst Pharmaceuticals for 4.1 Billion USD (3.5 Billion Euros), Entering the U.S. Market and Consolidating its Leadership in Brain Health and Rare Disease
2026-05-07 02:44U:CPRXNews ReleaseCatalyst Pharmaceuticals Announces Settlement of FIRDAPSE(TM) (amifampridine) Patent Litigation with Hetero Labs Ltd.
2026-04-28 08:03U:CPRXNews ReleaseCatalyst Pharmaceuticals to Report First Quarter 2026 Financial Results on May 11, 2026
2026-03-06 08:03U:CPRXNews ReleaseCatalyst Pharmaceuticals to Showcase Real-World Findings in Duchenne Muscular Dystrophy and Host Vamorolone-Focused Symposium at the 2026 MDA Clinical & Scientific Conference
2026-02-25 16:08U:CPRXNews ReleaseCatalyst Pharmaceuticals Reports Record Fourth Quarter and Record Full Year 2025 Financial Results and Provides 2026 Financial Guidance
2026-02-24 08:03U:CPRXNews ReleaseCatalyst Pharmaceuticals to Participate in the Barclays 28th Annual Global Healthcare Conference
2026-02-11 08:03U:CPRXNews ReleaseCatalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2025 Financial Results on February 25, 2026
2026-01-08 08:03U:CPRXNews ReleaseCatalyst Pharmaceuticals Receives Prestigious Ranking on Forbes 2026 List of America's Most Successful Small-Cap Companies
2026-01-05 08:03U:CPRXNews ReleaseThe University of Notre Dame and Catalyst Pharmaceuticals Host Inaugural Catalyst Advocacy Scholars Summit (CASS)
2025-12-15 08:03U:CPRXNews ReleaseCatalyst Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference
2025-11-24 08:03U:CPRXNews ReleaseCatalyst Pharmaceuticals to Participate in the Bank of America CNS Therapeutics Virtual Conference
2025-11-19 08:03U:CPRXNews ReleaseCatalyst Pharmaceuticals Recognized as One of North America's Fastest-Growing Companies on the 2025 Deloitte Technology Fast 500(TM)
2025-11-18 08:03U:CPRXNews ReleaseCatalyst Pharmaceuticals to Participate in Citi's 2025 Global Healthcare Conference
2025-11-05 16:07U:CPRXNews ReleaseCatalyst Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update